首页> 外文期刊>Xenobiotica: the fate of foreign compounds in biological systems >Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs
【24h】

Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs

机译:对雄性比格犬的胰高血糖素样肽-1(GLP-1)的代谢物GLP-1(9-36)酰胺的药代动力学和代谢研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

1. Glucagon-like peptide-1 (GLP-1)(7-36)amide is a 30-amino acid peptide hormone that is secreted from intestinal enteroendocrine L-cells in response to nutrients. GLP-1(7-36)amide possesses potent insulinotropic actions in the augmentation of glucose-dependent insulin secretion. GLP-1(7-36)amide is rapidly metabolized by dipeptidyl peptidase-IV to yield GLP-1(9-36)amide as the principal metabolite. Contrary to the earlier notion that peptide cleavage products of native GLP-1(7-36)amide [including GLP-1(9-36)amide] are pharmacologically inactive, recent studies have demonstrated cardioprotective and insulinomimetic effects with GLP-1(9-36)amide in mice, dogs and humans.
机译:1.胰高血糖素样肽-1(GLP-1)(7-36)酰胺是30-氨基酸肽激素,其响应于营养物质的肠道进肠癌L细胞分泌。 GLP-1(7-36)酰胺在增强葡萄糖依赖性胰岛素分泌中具有有效的胰岛素促进作用。 通过二肽基肽酶-IV快速地代谢GLP-1(7-36)酰胺,以产生GLP-1(9-36)酰胺作为主要代谢物。 与早期的观念相反,天然GLP-1(7-36)酰胺[包括GLP-1(9-36)酰胺]是药理学上无活性的,最近的研究已经证明了GLP-1的心脏保护和胰岛素效应(9 -36)酰胺在老鼠,狗和人类中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号